Chronic Leukemias and Lymphomas

1. Front Matter

   Pages i-ix

   PDF

2. Chronic Leukemias

   • Kanti R. Rai, Niraj Gupta

   Pages 1-21

3. Chronic Lymphocytic Leukemia

   • Jamie D. Cavenagh, T. Andrew Lister

   Pages 23-53

4. Hairy Cell Leukemia

   • Nicole Wentworth, Alan Saven

   Pages 55-78

5. Prolymphocytic Leukemias

   • Peter J. Rosen, Jonathan Said

   Pages 79-92

6. Chronic Myeloid Leukemia

   • Neil P. Shah, Charles L. Sawyers

   Pages 93-114

7. Sézary Syndrome

   • Lauren C. Pinter-Brown

   Pages 115-151

8. Large Granular Lymphocyte Proliferative Diseases

   • Mustafa Benekli, Maria R. Baer

   Pages 153-183

9. Myeloproliferative Syndromes

   • Nelida N. Sjak-Shie, Gary J. Schiller

   Pages 185-213

10. Advances in the Biology and Treatment of Multiple Myeloma

    • James R. Berenson, Robert A. Vescio

    Pages 215-248

11. Low-Grade Lymphoma

    • Christos Emmanouilides

    Pages 249-276

12. Aggressive Large-Cell Lymphomas

    • R. Gregory Bociek, James O. Armitage

    Pages 277-298

13. Hodgkin’s Disease

    • Steven M. Horwitz, Sandra J. Horning

    Pages 299-327

14. Back Matter

    Pages 329-342

    PDF

In Chronic Leukemias and Lymphomas: Clinical Management, a panel of recognized experts in hematological oncology describe the unique biological features of indolent hematologic neoplasms, providing powerful insight into their clinical manifestation, highlighting potential targets for novel therapies, and distinguishing these disorders from aggressive lymphoma and Hodgkin's disease. In their integrated surveys of these chronic myeloproliferative and lymphoproliferative disorders, the authors emphasize such unique entities as prolymphocytic leukemias and cutaneous lymphomas. Special emphasis is given to the mechanisms of disease progression with authoritative insights into the promising new era of antineoplastic pharmacology.

• Staging
• biology
• cell
• leukemia
• lymphoma
• oncology
• pathophysiology
• pharmacology
• physiology

"The book summarizes well the most recent insights into molecular pathogenesis of chronic hematologic diseases including chronic leukemias, myelo- and lymphoproliferative diseases, lymphomas and multiple myeloma, and their relevance for assessment of prognosis and management decisions. The results of trials evaluating novel targeted therapies are presented, succinctly providing reader with the most current information...This is a very useful book since it covers the most recent achievements and "hot" topics in chronic hematologic diseases in a concise format. The up-to-date information that it provides might not be available in larger textbooks, and thus it is highly recommended for practitioners and researchers." -Doody's Health Sciences Book Review Journal

• Division of Hematology-Oncology, UCLA School of Medicine, Los Angeles, USA

  Gary J. Schiller

Policies and ethics